Revenue
$1.95B
Fiscal year ended 2026-06-30Operating income
$215.42M
Fiscal year ended 2026-06-30Free cash flow
Unavailable
Fiscal year ended 2026-06-30Pediatrix Medical Group, Inc. (MD) reported revenue of $1.95B and net income of $174.81M for the fiscal year ended 2026-06-30. This page shows 1 annual period of income statement, balance sheet and cash flow figures normalized from Pediatrix Medical Group, Inc.’s SEC filings, each linked to the filing it came from.
Income
| Metric | 2026-06-30 |
|---|---|
| Revenue | $1.95B |
| Cost of revenue | Unavailable |
| Gross profit | Unavailable |
| Operating income | $215.42M |
| Net income | $174.81M |
| Research & development | Unavailable |
| Weighted-average diluted shares | Unavailable |
| Pretax income | $226.22M |
| Income tax expense | $51.41M |
| Diluted EPS | Unavailable |
| Selling, general & administrative | Unavailable |
| General & administrative | $248.03M |
| Selling & marketing | Unavailable |
Balance
| Metric | 2026-06-30 |
|---|---|
| Cash & equivalents | $288.88M |
| Total assets | $2.13B |
| Current assets | $660.14M |
| Total liabilities | $1.25B |
| Current liabilities | $501.58M |
| Total equity incl. NCI | $880.98M |
| Temporary (mezzanine) equity | Unavailable |
| Inventory | Unavailable |
| Accounts receivable | $227.60M |
| Goodwill | $1.27B |
| Long-term debt | $398.06M |
| Accounts payable | $27.85M |
Cash flow
| Metric | 2026-06-30 |
|---|---|
| Operating cash flow | $246.86M |
| Capital expenditures | Unavailable |
| Investing cash flow | -$9.64M |
| Financing cash flow | -$173.08M |
| Net change in cash | $64.15M |
| Stock-based compensation | $20.23M |
| Common dividends paid | Unavailable |
| Common share repurchases | $149.10M |
| Depreciation & amortization | $23.08M |
Derived
| Metric | 2026-06-30 |
|---|---|
| Free cash flow | Unavailable |
| Gross margin | Unavailable |
| Operating margin | 11.0% |
| FCF margin | Unavailable |
| SBC / revenue | 1.0% |
| Current ratio | 1.32x |
| Revenue YoY growth | 0.5% |
| Net margin | 9.0% |
| R&D / revenue | Unavailable |
| CapEx / revenue | Unavailable |
| Long-term debt / equity | 0.45x |
| Effective tax rate | 22.7% |
Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open MD in the interactive workspace to inspect any figure back to its filing.
Source filings
10-Q · Filed 2026-08-04View SEC filing
10-Q · Filed 2026-05-05View SEC filing
10-K · Filed 2026-02-19View SEC filing
10-Q · Filed 2025-11-03View SEC filing
10-Q · Filed 2025-08-05View SEC filing
10-Q · Filed 2025-05-06View SEC filing
Companies in the same industry
Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.